©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 111722
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.111722
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.111722
Figure 3 Morbidity and 90-day mortality in different classes of modified Charlson comorbidity index.
A: Morbidity; B: 90-day mortality. Blue bars: Relative frequency of patients with morbidity and mortality. Orange bars: Non-morbid patients.
- Citation: Rajan G, Sam AF, Rajakumar A, Jothimani D, Rela M. Application of modified Charlson comorbidity index for predicting outcomes following adult living donor liver transplantation. World J Hepatol 2026; 18(1): 111722
- URL: https://www.wjgnet.com/1948-5182/full/v18/i1/111722.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i1.111722